Search results for "Cannabi"

showing 10 items of 489 documents

Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice

2010

Background  Cannabinoid type 1 (CB1) receptors are involved in the regulation of gastrointestinal (GI) motility and secretion. Our aim was to characterize the roles of the CB1 receptor on GI motility and secretion in vitro and in vivo by using different classes of CB1 receptor antagonists. Methods  Immunohistochemistry was used to examine the localization of CB1 receptor in the mouse ileum and colon. Organ bath experiments on mouse ileum and in vivo motility testing comprising upper GI transit, colonic expulsion, and whole gut transit were performed to characterize the effects of the inverse agonist/antagonist AM251 and the neutral antagonist AM4113. As a marker of secretory function we mea…

AM251medicine.medical_specialtyCannabinoid receptorEndocrine and Autonomic SystemsPhysiologymedicine.medical_treatmentdigestive oral and skin physiologyGastroenterologyMotilityBiologyEndocrinologyRimonabantIn vivoInternal medicinemedicineInverse agonistCannabinoidReceptormedicine.drugNeurogastroenterology & Motility
researchProduct

Chicken adaptive response to low energy diet: main role of the hypothalamic lipid metabolism revealed by a phenotypic and multi-tissue transcriptomic…

2019

AbstractBackgroundProduction conditions of layer chicken can vary in terms of temperature or diet energy content compared to the controlled environment where pure-bred selection is undertaken. The aim of this study was to better understand the long-term effects of a 15%-energy depleted diet on egg-production, energy homeostasis and metabolism via a multi-tissue transcriptomic analysis. Study was designed to compare effects of the nutritional intervention in two layer chicken lines divergently selected for residual feed intake.ResultsChicken adapted to the diet in terms of production by significantly increasing their feed intake and decreasing their body weight and body fat composition, whil…

Adipose tissueadaptationEnergy homeostasisTranscriptome0302 clinical medicinehypothalamusBeta oxidation2. Zero hunger0303 health sciencesprise alimentaireEndocannabinoid systemAdaptation PhysiologicalCell biologyAlimentation et NutritionBody Composition[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]BiotechnologyResearch Articlelcsh:QH426-470FADS1FADS2lcsh:BiotechnologychickenpouletBiologyModels Biological03 medical and health sciencesQuantitative Trait Heritablelipidlcsh:TP248.13-248.65GeneticsAnimalsFood and Nutritionlipide030304 developmental biologyCaloric RestrictionNeurosciencesLipid metabolismLipid MetabolismDietlcsh:GeneticsGene Expression RegulationNeurons and Cognitionfeed intakeEnergy MetabolismChickenstranscriptome;lipid;feed intake;adaptation;hypothalamus;chickentranscriptome[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgery
researchProduct

Psychiatric comorbidity in compulsive sexual behavior disorder (CSBD)

2020

This is a post-print version of the paper. To cite this article: Ballester-Arnal, R., Castro-Calvo, J., Giménez-García, C., Gil-Juliá, B. & Gil-Llario, M.D (2020). Psychiatric comorbidity in Compulsive Sexual Behavior Disorder (CSBD). Addictive Behaviors, 107, 106384. https://doi.org/10.1016/j.addbeh.2020.106384 Compulsive Sexual Behavior Disorder (CSBD) is characterized by a persistent failure to control intense and recurrent sexual impulses, urges, and/or thoughts, resulting in repetitive sexual behavior that causes a marked impairment in important areas of functioning. Data collected from clinical populations suggest that CSBD frequently co-occurs with other Axis I and II psychiatric dis…

Adjustment disordersMedicine (miscellaneous)Alcohol abuseComorbidityToxicologyPrevalenceMedicineHumansSexual Dysfunctions PsychologicalBorderline personality disorderPsychiatric Status Rating ScalesDepressive Disorder Majorbiologybusiness.industryBulimia nervosaMental DisordersAlcohol dependencemedicine.diseasebiology.organism_classificationComorbidityDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical Psychologypsychiatric comorbidityCompulsive BehaviorAxis I and IIMajor depressive disorderCannabisCompulsive Sexual Behavior Disorder (CSBD)businessClinical psychologycluster analysis
researchProduct

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

2013

UNLABELLED: Cannabis use is associated with an earlier age of onset of psychosis (AOP). However, the reasons for this remain debated. METHODS: We applied a Cox proportional hazards model to 410 first-episode psychosis patients to investigate the association between gender, patterns of cannabis use, and AOP. RESULTS: Patients with a history of cannabis use presented with their first episode of psychosis at a younger age (mean years = 28.2, SD = 8.0; median years = 27.1) than those who never used cannabis (mean years = 31.4, SD = 9.9; median years = 30.0; hazard ratio [HR] = 1.42; 95% CI: 1.16-1.74; P < .001). This association remained significant after controlling for gender (HR = 1.39; 95% …

AdultAffective Disorders PsychoticMaleRiskage of onset cannabis drug use gender high-potency cannabis psychotic disorders survival plotsPsychosisPediatricsmedicine.medical_specialtySex FactorsDelta-9-tetrahydrocannabinolSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.medicineHumansAge of OnsetPsychiatrySettore MED/25 - PsichiatriaCannabisFirst episodebiologyProportional hazards modelHazard ratioRegular Articlemedicine.diseasebiology.organism_classificationPsychiatry and Mental healthPsychotic DisordersSchizophreniaFemaleCannabisAge of onsetPsychologySchizophrenia bulletin
researchProduct

Three de novo losses and one insertion within a pericentric inversion of chromosome 6 in a patient with complete absence of expressive speech and red…

2008

A 32-year-old female patient, observed for 30 years because of a distinctive phenotype consisting of a dysmorphic face non-progressive deficit of motor control, lack of speech development, reduced sensitivity to pain, with a known, complex interstitial deletion 6q14 within a de novo pericentric inversion 6p11.2;q15, was re-examined at the molecular level. Applying the Infinium HumanHap300 BeadChip array and BAC-based FISH we found two new non-contiguous microdeletions in addition to the one detected previously by high resolution G-band analysis. A 360 kb loss in band 6p12.3, containing the genes RHAG, CRISP1, 2, and 3, and PGK2, a 1.15 Mb loss in 6p12.2-p12.1, containing the genes PKHD1, IL…

AdultCell Adhesion Molecules NeuronalSingle-nucleotide polymorphismBiologySpeech DisordersReceptor Cannabinoid CB1GeneticsmedicineHumansGeneGenetics (clinical)Chromosomal inversionChromosome AberrationsFamily HealthGeneticsmedicine.diagnostic_testBrainChromosome MappingChromosomeGeneral MedicinePhenotypeFaceCytogenetic AnalysisRHAGSomatosensory Disordersbiology.proteinChromosomes Human Pair 6FemaleFluorescence in situ hybridizationSNP arrayEuropean Journal of Medical Genetics
researchProduct

IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use.

2019

Aims: Cognitive impairment is a possible indicator of neurodevelopmental impairment, but not all psychotic patients are cognitively compromised. It has been suggested that heavy cannabis use may precipitate psychosis in those who show no such compromise. This study compares two samples of patients with first-episode psychosis and their respective non-psychotic controls, in London (UK) and Palermo (Italy), and examines whether different patterns of cannabis use are reflected in differences in IQ. Methods: The two studies used the same inclusion/exclusion criteria and instruments. The sample comprised 249 subjects from London (106 patients and 143 controls) and 247 subjects from Palermo (120 …

AdultCross-Cultural ComparisonMalePsychosismedicine.medical_specialtyAdolescentIntelligenceNeurodevelopmentYoung Adult03 medical and health sciences0302 clinical medicineCognitionFirst episode psychosisLondonmedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansCognitive DysfunctionIn patientCannabiPsychiatryCognitive impairmentSettore MED/25 - PsichiatriaBiological PsychiatryMulticentric studybiologybusiness.industryConfoundingCognitionCannabis usemedicine.diseasebiology.organism_classification030227 psychiatryPsychiatry and Mental healthItalyPsychotic DisordersRisk factorsCase-Control StudiesFemaleMarijuana UseCannabisbusiness030217 neurology & neurosurgery
researchProduct

Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors

2016

Increasing evidence indicates that chronic stress, such as social isolation, plays an important role in the development of a variety of psychiatric and somatic disorders. Meanwhile, chronic stress imposed by prolonged isolation and confinement in the spacecraft is also one of the major concerns for the health of future interplanetary space travelers. Preclinical studies suggest that the peripheral endocannabinoid (eCB) system is involved in the regulation of the stress response and eCB signaling is implicated in the pathogenesis of stress-related diseases. However, there are only few human studies addressing this topic, of which most focusing on patients who have already developed a certain…

AdultMale0301 basic medicinemedicine.medical_specialty2-ArachidonoylglycerolArachidonic AcidsGlyceridesPathogenesis03 medical and health scienceschemistry.chemical_compoundCatecholamines0302 clinical medicineTandem Mass SpectrometrymedicineHumansChronic stressSocial isolationPsychiatryChromatography High Pressure LiquidBiological PsychiatryPsychiatric Status Rating ScalesPharmacologyStressorBrainElectroencephalographyAnandamideEndocannabinoid systemHealthy Volunteers030104 developmental biologychemistryLinear ModelsCatecholamineFemalemedicine.symptomPsychologyNeuroscienceStress Psychological030217 neurology & neurosurgeryEndocannabinoidsmedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Blood endocannabinoid levels in patients with panic disorder.

2020

Abstract Background The development and maintenance of anxiety disorders is not fully understood. There is consensus in the literature that in addition to genetic factors, social, psychological and neurobiological factors are of crucial importance. The present exploratory study investigates the influence of the endocannabinoids (EC) and related N-acylethanolamines (NA) on the maintenance of panic disorder (PD). Methods A total of n = 36 PD and n = 26 healthy controls (HC) were included in the study. Baseline characteristics showed no differences between the two groups. The participants were exposed to the Trier Social Stress Test (TSST) for reliable laboratory stress induction. Blood sample…

AdultMaleHypothalamo-Hypophyseal SystemHydrocortisoneEndocrinology Diabetes and MetabolismPhysiologyPituitary-Adrenal System03 medical and health sciences0302 clinical medicineEndocrinologyHeart RateTrier social stress testMedicineHumansSalivaBiological PsychiatryEndocrine and Autonomic Systemsbusiness.industryPanic disorderStressorRepeated measures designMiddle Agedmedicine.diseaseEndocannabinoid system030227 psychiatryPsychiatry and Mental healthEthanolaminesAnxietyPanic DisorderFemalemedicine.symptombusinessPsychosocial030217 neurology & neurosurgeryStress PsychologicalAgoraphobiaEndocannabinoidsPsychoneuroendocrinology
researchProduct

Comparison of Cortisol Stress Response in Patients with Panic Disorder, Cannabis-Induced Panic Disorder, and Healthy Controls

2018

&lt;b&gt;&lt;i&gt;Background/Aims:&lt;/i&gt;&lt;/b&gt; Little research effort has so far been dedicated to the analysis of the hypothalamic-pituitary-adrenal axis of aetiologically differing subgroups of patients with panic disorder (PD). The current study aimed at a deeper understanding of the cortisol stress response in cannabis-induced PD (CIPD) patients. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; Matched groups of 7 PD patients (mean age ± SD: 32.95 ± 9.04 years), 7 CIPD patients (31.94 ± 8.40 years), and 7 healthy controls (HC) (31.13 ± 8.57 years) were included in the study. The Trier Social Stress Test (TSST) was used for stress induction. Salivary cortisol samples were collected…

AdultMaleHypothalamo-Hypophyseal Systemendocrine systemmedicine.medical_specialtyHydrocortisoneSubstance-Related DisordersGastroenterologyFight-or-flight response03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesInternal medicinemedicineTrier social stress testHumansIn patientSalivaCannabisbiologyPanic disorderPanicbiology.organism_classificationmedicine.disease030227 psychiatryPsychiatry and Mental healthClinical Psychologymedicine.anatomical_structurePanic DisorderFemaleCannabismedicine.symptomPsychologyStress Psychological030217 neurology & neurosurgeryHypothalamic–pituitary–adrenal axisHormonal responsePsychopathology
researchProduct

Spinal Endocannabinoids and CB 1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization

2009

Plastic Pain Perception Drugs and endocannabinoids acting on cannabinoid (CB) receptors have potential in the treatment of certain types of pain. In the spinal cord they are believed to suppress nociception, the perception of pain and noxious stimuli. Pernia-Andrade et al. (p. 760 ) now find that endocannabinoids, which are released in spinal cord by noxious stimulation, may promote rather than inhibit nociception by acting on CB1 receptors. Endocannabinoids not only depress transmission at excitatory synapses in the spinal cord, but also block the release of inhibitory neurotransmitters, thereby facilitating nociception.

AdultMaleInterneuronPainMice TransgenicNeurotransmissionInhibitory postsynaptic potentialSynaptic TransmissionArticleRats Sprague-DawleyMiceYoung AdultPiperidinesReceptor Cannabinoid CB1InterneuronsCannabinoid Receptor ModulatorsmedicineAnimalsHumansPosterior Horn CellNerve Fibers UnmyelinatedMultidisciplinaryExcitatory Postsynaptic PotentialsNeural InhibitionAnatomySpinal cordElectric StimulationRatsMice Inbred C57BLPosterior Horn Cellsmedicine.anatomical_structureNociceptionInhibitory Postsynaptic PotentialsSpinal Cordnervous systemHyperalgesiaHyperalgesiaNeuropathic painPyrazolesFemaleRimonabantmedicine.symptomNeurosciencepsychological phenomena and processesEndocannabinoidsScience
researchProduct